BOSTON--(BUSINESS WIRE)--
Vertex
Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that it
will webcast its corporate presentation at the 35th Annual
J.P. Morgan Healthcare Conference on Monday, January 9 at 12:30 p.m. ET
(9:30 a.m. PT). The audio portion of management's remarks can be
accessed live through Vertex's website at www.vrtx.com
in the "Investors" section under the "Events and Presentations" page.
In addition, the company announced today that it will report its fourth
quarter and full year 2016 financial results on Wednesday, January 25
after the markets close. In conjunction with the announcement,
management will host a conference call that day at 4:30 p.m. ET. To
participate in the conference call, please dial (866) 501-1537 (U.S.) or
+1 (720) 545-0001 (International). The call will also be available as a
live and archived webcast on Vertex's website.
About Vertex
Vertex is a global biotechnology company that aims to discover, develop
and commercialize innovative medicines so people with serious diseases
can lead better lives. In addition to our clinical development programs
focused on cystic fibrosis, Vertex has more than a dozen ongoing
research programs aimed at other serious and life-threatening diseases.
Founded in 1989 in Cambridge, Mass., Vertex today has research and
development sites and commercial offices in the United States, Europe,
Canada and Australia. For seven years in a row, Science magazine
has named Vertex one of its Top Employers in the life sciences. For
additional information and the latest updates from the company, please
visit www.vrtx.com.
(VRTX-WEB)
View source version on businesswire.com: http://www.businesswire.com/news/home/20170104006393/en/
Vertex Pharmaceuticals Incorporated
Investors:
Michael
Partridge, 617-341-6108
or
Eric Rojas, 617-961-7205
or
Zach
Barber, 617-341-6470
Source: Vertex Pharmaceuticals Incorporated
News Provided by Acquire Media
